NTRA
Ticker
Natera, Inc.
NTRA · Healthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwideNatera, Inc. (NTRA), in the Healthcare sector, has 111 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 12 corporate insiders: 1 purchase and 110 sales, 4 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 16 and filed Sep 18. The most active filer was Solomon Moshkevich with 38 filings.
Add to watchlistFilings, ttm
111
1 buy · 110 sells · 4 late
Traders, ttm
13
1 congress · 12 insiders
Volume, ttmiDollar value disclosed in the window
$369.0M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 16
Filed Sep 17
ADViAverage daily dollar volume
$454.8M
market data
Share price · 12M
$328 (+83.1%)
Adjusted for splits and dividends.
Volume by month
Buys $24K
Sells $545.8M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
SMRecent filings
Jonathan SheenaSALE
Director
$3.0M8,650 sh across 4 lots
Exec Sep 15
Filed Sep 17 · 9:35 PM ET Matthew RabinowitzSALE EXECUTIVE CHAIRMAN $34.8M
102,000 sh across 29 lots
Exec Sep 14
Filed Sep 16 · 9:35 PM ET Matthew RabinowitzSALE EXECUTIVE CHAIRMAN $16.4M
50,000 sh across 6 lots
Exec Sep 11
Filed Sep 11 · 9:35 PM ET Solomon MoshkevichSALE PRESIDENT, CLINICALDIAGNOSTICS $5.9M
18,160 sh across 4 lots
Exec Sep 1
Filed Sep 3 · 9:35 PM ET Steven Leonard ChapmanSALE CEO AND PRESIDENT $545K
1,698 sh × $320.99
Exec Sep 1
Filed Sep 3 · 9:05 PM ET John FeskoSALE PRESIDENT, CHIEF BUS. OFFICER $2.1M
6,517 sh × $321.53
Exec Aug 10
Filed Aug 28 · 9:35 PM ET † Jonathan SheenaSALE Director $2.0M
6,000 sh × $325.32
Exec Aug 10
Filed Aug 14 · 9:35 PM ET † Matthew RabinowitzSALE EXECUTIVE CHAIRMAN $642K
2,000 sh × $320.90
Exec Aug 7
Filed Aug 7 · 9:35 PM ET Jonathan SheenaSALE Director $2.8M
8,750 sh across 7 lots
Exec Aug 7
Filed Aug 7 · 9:35 PM ET Michael Burkes BrophySALE CHIEF FINANCIAL OFFICER $131K
478 sh × $274.22
Exec Aug 4
Filed Aug 5 · 9:35 PM ET Steven Leonard ChapmanSALE CEO AND PRESIDENT $659K
2,470 sh across 3 lots
Exec Aug 3
Filed Aug 5 · 9:35 PM ET Solomon MoshkevichSALE PRESIDENT, CLINICALDIAGNOSTICS $690K
2,590 sh across 3 lots
Exec Aug 3
Filed Aug 5 · 9:35 PM ET Matthew RabinowitzSALE EXECUTIVE CHAIRMAN $196K
731 sh × $267.99
Exec Aug 3
Filed Aug 5 · 9:35 PM ET Matthew RabinowitzSALE EXECUTIVE CHAIRMAN $448K
1,718 sh × $260.49
Exec Jul 27
Filed Jul 29 · 9:35 PM ET Daniel RabinowitzSALE SEC. AND CHIEF LEGAL OFFICER $485K
1,887 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET Solomon MoshkevichSALE PRESIDENT, CLINICALDIAGNOSTICS $569K
2,214 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET John FeskoSALE PRESIDENT, CHIEF BUS. OFFICER $440K
1,713 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET Steven Leonard ChapmanSALE CEO AND PRESIDENT $1.5M
5,770 sh across 2 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET Michael Burkes BrophySALE CHIEF FINANCIAL OFFICER $1.2M
4,894 sh across 4 lots
Exec Jul 27
Filed Jul 29 · 9:35 PM ET Jonathan SheenaSALE Director $229K
840 sh across 2 lots
Exec Jul 15
Filed Jul 17 · 9:05 PM ET Jonathan SheenaSALE Director $837K
3,150 sh across 6 lots
Exec Jul 13
Filed Jul 15 · 9:05 PM ET Matthew RabinowitzSALE EXECUTIVE CHAIRMAN $280K
1,000 sh × $280.00
Exec Jul 6
Filed Jul 8 · 9:05 PM ET Daniel RabinowitzSALE SEC. AND CHIEF LEGAL OFFICER $4.5M
16,500 sh across 11 lots
Exec Jul 1
Filed Jul 6 · 9:05 PM ET Solomon MoshkevichSALE PRESIDENT, CLINICALDIAGNOSTICS $710K
2,600 sh × $272.99
Exec Jul 1
Filed Jul 6 · 9:05 PM ET Herm RosenmanSALE Director $4.1M
16,530 sh × $250.00
Exec Jun 24
Filed Jun 26 · 5:30 PM ET